LDL cholesterol as a strong predictor of coronary heart disease in diabetic individuals with insulin resistance and low LDL: The Strong Heart Study

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 20, Issue 3, 2000, Pages 830-835

  Howard, Barbara V ^a   Robbins, David C ^a   Sievers, Maurice L ^g   Lee, Elisa T ^b   Rhoades, Dorothy ^h   Devereux, Richard B ^d   Cowan, Linda D ^c   Gray, R Stuart ^e   Welty, Thomas K ^f   Go, Oscar T ^b   Howard, Wm James ^a  

^a MEDSTAR RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^c UNIVERSITY OF OKLAHOMA   (United States)

^d Department of Molecular Biology and Genetics   (United States)

^e ST JOHN'S HOSPITAL   (United Kingdom)

^f Aberdeen Area Tribal Chairmen's Health Board   (United States)

^g NATIONAL INSTITUTES OF HEALTH   (United States)

^h MedStar Research Institute ^*

Author keywords

Coronary heart disease; Diabetes mellitus; Indians; Insulin resistance; Low density lipoprotein cholesterol; North American

Indexed keywords

ALBUMIN; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; AGED; AMERICAN INDIAN; ARTICLE; BODY FAT; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; FIBRINOGEN BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PARTICLE SIZE; PREDICTION; PRIORITY JOURNAL; PROTEINURIA; RISK ASSESSMENT; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0034016466     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.20.3.830     Document Type: Article

References (43)

1. World Health Organization. Prevention of diabetes mellitus. In: WHO Technical Report Series #844. Geneva, Switzerland: World Health Organization; 1994.
2. Wingard DL, Barrett-Connor E. Heart disease and diabetes. In: National Diabetes Data Group, ed. Diabetes in America. 2nd ed. Bethesda, Md: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. NIH publication No. 95-1468, 1995:429-448.
3. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339:229-234.
4. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care. 1993;16: 434-444.
5. Kannel WB, Higgins M. Smoking and hypertension as predictors of cardiovascular risk in population studies. J Hypertens. 1990;8(suppl 8):S3-S8.
6. Castelli WP. The triglyceride issue: a view from Framingham. Am Heart J. 1986;112:432-437.
7. Castelli WP. Epidemiology of triglycerides: a view from Framingham. Am J Cardiol. 1992;70:3H-9H.
8. Suarez L, Barrett-Connor E. Interaction between cigarette smoking and diabetes mellitus in the prediction of death attributed to cardiovascular disease. Am J Epidemiol. 1984;120:670-675.
9. Cowie CC, Howard BV, Harris MI. Serum lipoproteins in African Americans and Whites with non-insulin-dependent diabetes in the US population. Circulation. 1994;90:1185-1193.
10. Pyorala K, Pedersen TR, Kjekshus J, Faergeman O, Olsson AG, Thorgeirsson G. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. Diabetes Care. 1997;20:614-620.
11. Sacks FM, Pfeffer AM, Moye LA, Rouleau JL, Rutherford JD, Cole TG, Brown L, Warnica JW, Arnold JMO, Wun C-C, Davis BR, Braunwald E. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med. 1996;335: 1001-1009.
12. Downs JR, Clearfield M, Weis S, Whitney E, Shapiro DR, Beere PA, Langendorfer A, Stein EA, Kruyer W, Gotto AM Jr. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS: Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA. 1998;279:1615-1622.
13. Robbins DC, Welty TK, Wang WY, Lee ET, Howard BV. Plasma lipids and lipoprotein concentrations among American Indians: comparison with the US population. Curr Opin Lipidol. 1996;7:188-195.
14. Lee ET, Welty TK, Fabsitz R, Cowan LD, Lee N-A, Oopik AJ, Cucchiara AJ, Savage PJ, Howard BV. The Strong Heart Study: a study of cardiovascular disease in American Indians: design and methods. Am J Epidemiol. 1990;132:1141-1155.
15. Howard BV, Welty TK, Fabsitz RR, Cowan LD, Oopik AJ, Le NA, Yeh J, Savage PJ, Lee ET. Risk factors for coronary heart disease in diabetic and nondiabetic Native Americans: the Strong Heart Study. Diabetes. 1992;41(suppl 2):4-11.
16. Stoddart M, Jarvis B, Blake B, Fabsitz RR, Welty TK, Lee ET, Howard BV. Recruitment of American Indians in epidemiologic research: the Strong Heart Study. Harvard J Minority Public Health. In press.
17. Lipid Research Clinics Program. Manual of Laboratory Operations. Vol. 1. Washington, DC: Department of Health, Education, and Welfare (DHEW publication No. 75-628); May 1994.
18. Morgan C, Lazarow A. Immunoassay of insulin: two antibody system: plasma insulin levels in normal, subdiabetic and diabetic rats. Diabetes. 1963;12:115-126.
19. von Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol. 1957;17:237-246.
20. Little RR, England JD, Wiedmeyer HM, McKenzie EM, Mitra R, Erhart PM, Durham JB, Goldstein DE. Interlaboratory standardization of glycated hemoglobin determinations. Clin Chem. 1986;32:358-360.
21. Vasquez B, Flock EV, Savage PJ, Nagulesparan M, Bennion LJ, Baird HR, Bennett PH. Sustained reduction of proteinuria in type 2 (non-insulin dependent) diabetes following diet-induced reduction of hyperglycemia. Diabetologia. 1984;26:127-133.
22. Chasson AL, Grady HJ. Stanley MA. Determination of creatinine by means of automatic chemical analysis. Tech Bull Regist Med Technol. 1960;30:207-212.
23. Prineas RJ, Crow RS, Blackburn H. The Minnesota Code Manual of Electrocardiographic Findings. Littleton, Mass: John Wright PSC; 1982.
24. Rose GA, Blackburn H. Cardiovascular survey methods. 2nd ed. Geneva, Switzerland: World Health Organization; 1982. Monograph series No. 56G.
25. WHO Expert Committee on Diabetes Mellitus. Second Report. Geneva, Switzerland: World Health Organization: 1980. Technical report series 646.
26. American Diabetes Association. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: clinical practice recommendations. 1998. Diabetes Care. 1998;21(suppl 1):S5-S19.
27. National Heart, Lung, and Blood Institute. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNCV). Arch Intern Med. 1993;153:154-183.
28. Bennett PH, Nelson RG, Knowler WC, Hardy SA, Williams GW, Pettitt DJ, Saad MF, Mitch WB, Myers BD. Urine albumin/creatinine ratio estimates albumin excretion and predicts nephropathy in type II (non-insulin dependent) diabetes. Diabetologia. 1990;33(Suppl):A147. Abstract.
29. Lee ET, Cowan LD, Howard WJ, Sievers M, Welty TK, Wang W, Yeh JL, Rhoades ER, Devereux RB, Fabsitz RR, Go O, Howard BV. All-cause mortality and cardiovascular disease mortality in three American Indian populations, aged 45-74 years, 1984-1988: the Strong Heart Study. Am J Epidemiol. 1998;147:995-1008.
30. Welty TK, Lee ET, Yeh J, Cowan LD, Go O, Fabsitz RR, Le NA, Oopik AJ, Robbins DC, Howard BV. Cardiovascular disease risk factors among American Indians, the Strong Heart Study. Am J Epidemiol. 1995;142: 269-287.
31. Howard BV, Cowan LD, Go O, Welty TK, Robbins DC, Lee ET. Adverse effects of diabetes on multiple cardiovascular disease risk factors in women: the Strong Heart Study. Diabetes Care. 1998;21:1258-1265.
32. Howard BV, Lee ET, Cowan LD, Fabsitz RR, Howard WJ, Oopik AJ, Robbins DC, Savage PJ, Yeh JL, Welty TK. Coronary heart disease prevalence and its relation to risk factors in American Indians: the Strong Heart Study. Am J Epidemiol. 1995;142:254-268.
33. Howard BV. Pathogenesis of diabetic dyslipidemia. Diabetes Rev. 1995; 3:423-432.
34. Mitchell BD, Haffner SM, Hazuda HP, Patterson JK, Stern MP. Diabetes and coronary heart disease risk in Mexican Americans. Ann Epidemiol. 1992;2:101-106.
35. Reaven GM. Non-insulin-dependent diabetes mellitus, abnormal lipoprotein metabolism, and atherosclerosis. Metabolism. 1987;36(suppl 1):1-8.
36. Gordon T, Kannel WB, Castelli WP, Dauber TR. Lipoproteins, cardiovascular disease, and death: the Framingham Study. Arch Int Med. 1981; 141:1128-1131.
37. Austin MA, Mykkanen L, Kuusisto J, Edwards KL, Nelson C, Haffner SM, Pyorala K, Laakso M. Prospective study of small LDLs as a risk factor for non-insulin dependent diabetes mellitus in elderly men and women. Circulation. 1995;92:1770-1778.
38. Fontbonne AM, Eschwege EM. Insulin and cardiovascular disease: Paris Prospective Study. Diabetes Care. 1991;14:461-469.
39. Borch-Johnsen K, Kreiner S. Proteinuria: value as a predictor of cardiovascular mortality in insulin-dependent diabetes mellitus. Br Med J. 1987;294:1651.
40. Parving HH, Gall MA, Nielsen FS. Dyslipidaemia and cardiovascular disease in non-insulin-dependent diabetic patients with and without diabetic nephropathy. J Intern Med. 1994;736(suppl):89-94.
41. Savage S, Estacio RO, Jeffers B, Schrier RW. Urinary albumin excretion as a predictor of diabetic retinopathy, neuropathy, and cardiovascular disease in NIDDM. Diabetes Care. 1996;19:1243-1248.
42. Nelson RG, Pettitt DJ, Carraher MJ, Baird HR, Knowler WC. Effect of proteinuria on mortality in NIDDM. Diabetes. 1988;37:1449-1508.
43. Fagot-Campagna A, Hanson RL, Narayan KM, Sievers ML, Pettitt DJ, Nelson RG, Knowler WC. Serum cholesterol and mortality rates in a Native American population with low cholesterol concentrations: a U-shaped association. Circulation. 1997;96:1408-1415.